BioImpact Capital LLC, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 192,912 shares at $28.97 ($5.5M) on 2021-09-09, disclosed to the SEC on 2021-09-13.
Open-market sale of $5.5M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.97 | 38,028 | $1.1M | 20.2% |
| 2 | $28.97 | 38,028 | $1.1M | 20.2% |
| 3 | $27.86 | 11,313 | $315K | 5.8% |
| 4 | $27.86 | 11,313 | $315K | 5.8% |
| 5 | $28.73 | 11,330 | $326K | 6.0% |
| 6 | $28.73 | 11,330 |
| $326K |
| 6.0% |
| 7 | $27.64 | 35,785 | $989K | 18.1% |
| 8 | $27.64 | 35,785 | $989K | 18.1% |
| Total | $28.32 avg | 192,912 | $5.5M | 100% |
| Filing → |
| CGEM | SELL | 2021-09-20 | $182K | — | Filing → |
| CGEM | SELL | 2021-09-16 | $602K | — | Filing → |
| CGEM | SELL | 2021-09-13 | $1.4M | — | Filing → |